ZA934772B - Assay system for degenerative muscle disease - Google Patents

Assay system for degenerative muscle disease

Info

Publication number
ZA934772B
ZA934772B ZA934772A ZA934772A ZA934772B ZA 934772 B ZA934772 B ZA 934772B ZA 934772 A ZA934772 A ZA 934772A ZA 934772 A ZA934772 A ZA 934772A ZA 934772 B ZA934772 B ZA 934772B
Authority
ZA
South Africa
Prior art keywords
assay system
muscle disease
degenerative muscle
degenerative
denervated
Prior art date
Application number
ZA934772A
Other languages
English (en)
Inventor
Nancy Y Ip
Peter S Distefano
Neil Stahl
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of ZA934772B publication Critical patent/ZA934772B/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2878Muscular dystrophy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA934772A 1992-07-02 1993-07-02 Assay system for degenerative muscle disease ZA934772B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/907,680 US5360740A (en) 1992-07-02 1992-07-02 Assay system for degenerative muscle disease

Publications (1)

Publication Number Publication Date
ZA934772B true ZA934772B (en) 1994-01-20

Family

ID=25424468

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA934772A ZA934772B (en) 1992-07-02 1993-07-02 Assay system for degenerative muscle disease

Country Status (10)

Country Link
US (1) US5360740A (de)
EP (1) EP0648336B1 (de)
JP (1) JP3202019B2 (de)
AT (1) ATE148231T1 (de)
AU (1) AU672419B2 (de)
CA (1) CA2139239A1 (de)
DE (1) DE69307707D1 (de)
IL (1) IL106219A (de)
WO (1) WO1994001779A1 (de)
ZA (1) ZA934772B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0632008T3 (da) * 1993-06-01 1998-09-23 Ono Pharmaceutical Co Pentansyrederivater
FR2984358A1 (fr) * 2011-12-16 2013-06-21 Genethon Methodes pour le diagnostic de dystrophies musculaires

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor
US4997929A (en) * 1989-01-05 1991-03-05 Synergen, Inc. Purified ciliary neurotrophic factor
IL98304A (en) 1990-06-01 2008-08-07 Regeneron Pharma The ciliary neurotrophic factor receptor

Also Published As

Publication number Publication date
AU672419B2 (en) 1996-10-03
JP3202019B2 (ja) 2001-08-27
EP0648336B1 (de) 1997-01-22
CA2139239A1 (en) 1994-01-20
IL106219A (en) 1998-02-08
US5360740A (en) 1994-11-01
EP0648336A1 (de) 1995-04-19
WO1994001779A1 (en) 1994-01-20
IL106219A0 (en) 1993-11-15
JPH07509063A (ja) 1995-10-05
ATE148231T1 (de) 1997-02-15
DE69307707D1 (de) 1997-03-06
AU4673593A (en) 1994-01-31

Similar Documents

Publication Publication Date Title
FR2595817B1 (fr) Procede de determination de l'orientation d'une plate-forme de capteur imageur ou instrument analogue
AU5667698A (en) Method and apparatus for supporting an element to be supported, in particular a patient's body for maintaining it at a predetermined water line
IL117021A0 (en) Assay device for detecting the presence of an analyte
WO1997014355A3 (en) Exciter-detector unit for measuring physiological parameters
EP0653718A3 (de) Vorrichtung und Verfahren zur Erfassung körperspezifischer Messdaten.
DK148191A (da) Cyclon separator til fjernelse og genvinding af luftbaarne partikler
FR2645954B1 (fr) Procede de determination d'une position utilisant des satellites
ES516533A0 (es) "un dispositivo para la exploracion de objetos, especialmente tejidos biologicos, mediante ecografia de ultrasonidos".
WO1997021811A3 (en) Novel tyrosine kinase receptors and ligands
FR2688855B1 (fr) Dispositif indicateur de la position d'une vanne.
AU8347391A (en) Simultaneous assay for detecting one or more analytes
EP0487650A4 (en) Blotting technique for membrane assay
HUP9800225A3 (en) Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds
IL106219A0 (en) Assay system for degenerative muscle disease
HU9400769D0 (en) Method for the detection of gastric epithelial damage
TNSN86154A1 (fr) Procede pour la preparation de cefodizime
EP0298411A3 (en) Self diagnostic apparatus for vehicle meter
FR2682028B1 (fr) Procede, dispositif et appareillage pour l'obtention d'une empreinte de la surface d'un objet ou d'une partie du corps.
EP0238757A3 (en) Improvements in and relating to a roof raising mechanism for a trailer or van body construction
FR2620511B1 (fr) Dispositif de liaison pour profiles tubulaires
FR2719896B1 (fr) Dispositif pour la détermination de l'écart entre deux mesures linéaires.
GB9314011D0 (en) New diagnostic assay for detection of syphilis
AU591352B2 (en) Sensor of the enzyme-electrode type and its use for determining an analyte
CA2102115A1 (en) In vitro methods for determining in vivo thrombotic events
FR2741519B1 (fr) Appareillage portatif et procede pour effectuer par intermittence et enregistrer des mesures recurrentes, notamment sur le corps humain, telles que des mesures de pression arterielle